XML 30 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Note 8 - Fair Value Measurements
12 Months Ended
Jan. 01, 2023
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

NOTE 8 FAIR VALUE MEASUREMENTS

 

The Company's cash, cash equivalents and restricted cash balances were $19.2 million and $19.6 million, including amounts in money market funds, as of January 1, 2023 and January 2, 2022, respectively. The money market funds are collateral for the company's credit card debt and had a balance of $0.1 million at January 1, 2023 and January 2, 2022. Interest in these funds is earned at a 0.01% annual percentage rate ( "APR"). Due to the short-term nature of the money market funds, the Company believes that carrying value approximates fair value.

 

In the third quarter of 2021, in connection with a revenue contract with a non-affiliated customer, the Company received shares of the customer's common stock. The full transaction price under the revenue contract was cash plus a non-cash consideration which consisted of a certain amount of the customer's equity. The Company considered the non-cash consideration to be an investment in the customer. The full transaction price was the amount of consideration which the Company received under the contract in exchange for transferring the promised goods and services to the customer. Since the non-cash consideration were shares of common stock that were not publicly traded, the fair value was not readily determinable. The Company considered various valuation methods such as market multiples, guideline public company method, and the Black-Scholes Option Pricing model. Due to limited data for the valuation, the Company ultimately selected the Black Scholes method using back-solve techniques as that was determined to be the most suitable with the available data. The Black Scholes Option Pricing model is a valuation approach that can be used to determine the value of common shares for companies in which there are no, or infrequent, transactions involving common shares. The Company believed that its valuation method for the non-public equity under this arrangement fell under Level 3 in the fair value hierarchy because the value method relied on unobservable market inputs. The initial fair value of the non-cash consideration is listed below: 

 

  

Fair Value at Valuation Date Using:

 
  

Total

  

Quoted Prices in Active Markets for Identical Assets (Level I)

  

Significant Other Observable Inputs (Level 2)

  

Significant Unobservable Inputs (Level 3)

 

Non-marketable equity investment

 $300  $  $  $300 
                 

 

In arriving at the estimated value for the non-cash consideration, the Company utilized inputs relying on significant judgment in accordance with the AICPA Accounting and Valuation Guide, Valuation of Privately Held Company Equity Securities Issued as Compensation (2013). The key assumptions below were utilized:   

 

•  Discount for lack of marketability: 34% - 41%.
•  Expected Term: 4 - 5 Years.
•  Risk Free Interest Rate: 0.75% - 0.92%.
•  Dividend: 0.00.   
•  Volatility: 63% - 78%.
 
Volatility was estimated by utilizing a selected peer group of companies within the customers’ industry with a valuation date as of  October 2021. 
 
After initial recognition fair value of the non-cash consideration, the Company elected to utilize the practical expedient under ASC 321 by which entities can elect to measure equity securities without readily determinable fair values at “cost minus impairment,” basis for periods subsequent to the acquisition date. Under the “cost minus impairment” methods, when the investment is determined to be impaired on the basis of a qualitative assessment, or there is an observable price change in an orderly transaction, entities that have made the election in ASC 321 must remeasure such equity securities at fair value in accordance with ASC8 20. ASC 321 indicates that the adjustments to the carrying value of an equity security without a readily determinable fair value should reflect the fair value of the security as of the date that the observable transaction for the similar security took place. 

 

Subsequent to the valuation date and through January 2, 2022, there were no observable indicators of impairment for the non-marketable equity investment. During Fiscal 2022, there were no observable indicators of impairment for the non-marketable equity investment. There was no change to the carrying value of the non-marketable equity investment as of January 1, 2023 and January 2, 2022.

 

The carrying amount of the non-marketable equity investment was $0.3 million as of as of January 1, 2023 and January 2, 2022.